Therapeutic efficacy of artemether–lumefantrine and artesunate–amodiaquine for the treatment of uncomplicated Plasmodium falciparum malaria in Mali, 2015–2016

Therapeutic efficacy of artemether–lumefantrine and artesunate–amodiaquine for the treatment of uncomplicated Plasmodium falciparum malaria in Mali, 2015–2016

Abstract Background The current first-line treatments for uncomplicated malaria recommended by the National Malaria Control Programme in Mali are artemether–lumefantrine (AL) and artesunate–amodiaquine (ASAQ). From 2015 to 2016, an in vivo study was carried out to assess the clinical and parasitolog...

Full description

Bibliographic Details
Main Authors: Youssouf Diarra, Oumar Koné, Lansana Sangaré, Lassina Doumbia, Dade Bouye Ben Haidara, Mouctar Diallo, Ababacar Maiga, Hamadoun A. Sango, Halidou Sidibé, Jules Mihigo, Douglas Nace, Dragan Ljolje, Eldin Talundzic, Venkatachalam Udhayakumar, Erin Eckert, Celia J. Woodfill, Leah F. Moriarty, Pharath Lim, Donald J. Krogstad, Eric S. Halsey, Naomi W. Lucchi, Ousmane A. Koita
Format: Article
Language:English
Published: BMC 2021-05-01
Series:Malaria Journal
Subjects:
Malaria
Antimalarial resistance
Efficacy
Mali
Artemether–lumefantrine
Artesunate–amodiaquine
Online Access:https://doi.org/10.1186/s12936-021-03760-9

Internet

https://doi.org/10.1186/s12936-021-03760-9

Similar Items